Biomedical Engineering Reference
In-Depth Information
3. Hohman M , Gregory K , Chibale K , Smith PJ , Ekins S , Bunin B . Novel web - based
tools combining chemistry informatics, biology and social networks for drug dis-
covery .
Drug Discov Today
2009 ; 14 : 261 - 270 .
4. Bailey DS , Zanders ED . Drug discovery in the era of Facebook — New tools for
scientifi c networking.
Drug Discov Today
2008 ; 13 : 863 - 868 .
5. Ekins S , Williams AJ . Precompetitive preclinical ADME/Tox data: Set it free on the
web to facilitate computational model building to assist drug development.
Lab on
a Chip
2010 ; 10 : 13 - 22 .
6. Gupta RR , Gifford EM , Liston T , Waller CL , Bunin B , Ekins S .
Using open source
computational tools for predicting human metabolic stability and additional ADME/
TOX properties
.
Drug Metab Disposition
, doi: 10.1124/dmd.110.034918.
7. Kirschner NM , Pauker SG , Stubbs JW . How can cost - effectiveness information help
control unsustainable growth in U.S. health care spending?
Ann Intern Med
2009 ; 150 : 57 .
8. Arnold RJ , Gabrail N , Raut M , Kim R , Sung JC , Zhou Y . Clinical implications of
chemotherapy-induced diarrhea in patients with cancer.
J Support Oncol
2005 ; 3 : 227 - 232 .
9. Walker A , McMurray J , Stewart S , Berger W , McMahon AD , Dargie H. Economic
evaluation of the impact of nicorandil in angina (IONA) trial.
Heart
2006 ; 92 :
619 - 624 .
10. Beinart SC , Kolm P , Veledar E , Zhang Z , Mahoney EM , Bouin O . Long - term cost
effectiveness of early and sustained dual oral antiplatelet therapy with clopidogrel
given for up to one year after percutaneous coronary intervention results: From
the clopidogrel for the reduction of events during observation (CREDO) trial.
J
Am Coll Cardiol
2005 ; 46 : 761 - 769 .
11. Elliott RA , Hooper L , Payne K , Brown TJ , Roberts C , Symmons D . Preventing
non - steroidal anti - infl ammatory drug-induced gastrointestinal toxicity: Are older
strategies more cost-effective in the general population?
Rheumatol (Oxford)
2006 ; 45 : 606 - 613 .
12. Gaziano TA , Opie LH , Weinstein MC . Cardiovascular disease prevention with a
multidrug regimen in the developing world: A cost-effectiveness analysis.
Lancet
2006 ; 368 : 679 - 686 .
13. Parashar U , Bresee J , Widdowson M , Gentsch J . New breath for rotavirus vaccines .
Drug Discov Today Ther Strategies
2006 ; 3 : 159 - 165 .
14. Simon J , Gray A , Duley L . Cost - effectiveness of prophylactic magnesium sulphate
for 9996 women with pre-eclampsia from 33 countries: Economic evaluation of the
Magpie Trial.
Bjog
2006 ; 113 : 144 - 151 .
15. Sullivan SD , Lee TA , Blough DK , Finkelstein JA , Lozano P , Inui TS . A multisite
randomized trial of the effects of physician education and organizational change
in chronic asthma care: Cost-effectiveness analysis of the Pediatric Asthma Care
Patient Outcomes Research Team II (PAC-PORT II).
Arch Pediatr Adolesc Med
2005 ; 159 : 428 - 434 .
16. Arnold RJ. Cost - effectiveness analysis: Should it be required for drug registration
and beyond?
Drug Discov Today
2007 ; 12 : 960 - 965 .
17. Hakim Z. Using decision - analytic models wisely .
J Manag Care Pharm
2003 ; 9 :
449 - 450 .
Search WWH ::
Custom Search